| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:06 | INTUITIVE SURGICAL - Heftiger Kurseinbruch vor den Zahlen | 5 | stock3.com | ||
| Di | Here's Exactly Why Intuitive Surgical Stock Is Floundering in 2026 | 36 | The Motley Fool | ||
| Di | INTUITIVE SURGICAL INC - Schwäche trifft auf Bewertungsschärfe | 118 | Maximilian Berger | ||
| Di | Stifel reiterates Intuitive Surgical stock rating on competitive edge | 123 | Investing.com | ||
| INTUITIVE SURGICAL INC CDR Aktie jetzt für 0€ handeln | |||||
| Mo | TD Cowen cuts Intuitive Surgical stock price target on valuation | 49 | Investing.com | ||
| Mo | Bewertungssorgen: TD Cowen senkt Kursziel für Intuitive Surgical | 96 | Investing.com Deutsch | ||
| Mo | Intuitive Surgical Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call | 22 | Benzinga.com | ||
| Fr | ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? | 41 | Zacks | ||
| 07.07. | How Big Is the Appendectomy Opportunity for ISRG's Robotic Expansion? | 20 | Zacks | ||
| 06.07. | Prediction: Intuitive Surgical Will Be Worth $500 Billion by 2031 -- Here's Why | 29 | The Motley Fool | ||
| 06.07. | Intuitive Surgical-Aktie: Dreht die Aktie wieder nach oben? | 717 | sharedeals.de | Die Aktie von Intuitive Surgical zeigt nach den deutlichen Kursverlusten der vergangenen Monate wieder erste Erholungstendenzen. Neben starken Fundamentaldaten sorgen auch positive Analysteneinschätzungen... ► Artikel lesen | |
| 03.07. | Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong -- and History Is on Its Side. | 39 | The Motley Fool | ||
| 03.07. | Intuitive Surgical's Quarterly Earnings Preview: What You Need to Know | 33 | Barchart.com | ||
| 02.07. | Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast | 27 | Insider Monkey | ||
| 01.07. | Intuitive Surgical's Moat Is Getting Stronger. Is This the Closest Thing to a 'Forever' Stock? | 30 | The Motley Fool | ||
| 27.06. | Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy. | 43 | The Motley Fool | ||
| 26.06. | Piper Sandler Highlights Intuitive Surgical (ISRG) on Long-Term Growth Catalysts | 27 | Insider Monkey | ||
| 24.06. | ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now? | 23 | Zacks | ||
| 22.06. | Opening Bell: Microsoft, Chevron, GE Vernova, Caterpillar, SpaceX, Apple, Bloom, Intuitive Surgical | 1.443 | Der Aktionär TV | Die US-Börsen sind am Donnerstag mit einer Erholungsbewegung in das verlängerte Wochenende gegangen. Der Dow Jones ' schloss mit einem moderaten Plus von 0,14 Prozent. Deutlich freundlicher präsentierte... ► Artikel lesen | |
| 20.06. | Intuitive Surgical (ISRG) Promotes Taylor Patton to Chief Commercial and Marketing Officer | 7 | Insider Monkey |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 335,40 | +0,92 % | INTUITIVE SURGICAL - Heftiger Kurseinbruch vor den Zahlen | ||
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 6,290 | +0,16 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| CLEARPOINT NEURO | 15,960 | 0,00 % | EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery |